Literature DB >> 8879222

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain.

P Dowling1, G Shang, S Raval, J Menonna, S Cook, W Husar.   

Abstract

Immunohistochemical methods were used to search for Fas receptor/Fas ligand system involvement in multiple sclerosis (MS) white matter brain lesions. We found large numbers of Fas ligand (Fas-L)-bearing cells present in two acute lesions and 12 of 16 chronic MS lesions, and very few positive cells in non-inflammatory controls. Four of six brains from non-MS neuropathologic conditions associated with inflammation and white matter disease were, however, also positive for Fas-L. Double staining with cell-specific markers revealed that the pattern of ligand-positive cells in chronic MS lesions was complex and composed of several different cell types which were primarily resident glial cells with a small overlay of macrophages. Fas/APO 1 (CD95) receptor expression in MS tissue was also evaluated and marked upregulation of the receptor was found. In addition, Fas receptor was induced, but to a lesser extent, in numerous control brains. The observations that TUNEL-positive dying cells were present in MS lesions and showed excellent co-localization with Fas-L, indicate that the Fas death system may contribute to plaque pathogenesis and could lead to the development of a new category of therapeutic agents for MS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8879222      PMCID: PMC2192814          DOI: 10.1084/jem.184.4.1513

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen.

Authors:  R Watanabe-Fukunaga; C I Brannan; N Itoh; S Yonehara; N G Copeland; N A Jenkins; S Nagata
Journal:  J Immunol       Date:  1992-02-15       Impact factor: 5.422

2.  Fas ligand-induced apoptosis as a mechanism of immune privilege.

Authors:  T S Griffith; T Brunner; S M Fletcher; D R Green; T A Ferguson
Journal:  Science       Date:  1995-11-17       Impact factor: 47.728

Review 3.  Immunologic mechanisms and therapy in multiple sclerosis.

Authors:  D A Hafler; H L Weiner
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

4.  A novel domain within the 55 kd TNF receptor signals cell death.

Authors:  L A Tartaglia; T M Ayres; G H Wong; D V Goeddel
Journal:  Cell       Date:  1993-09-10       Impact factor: 41.582

5.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  Fas antigen expression in brains of patients with Alzheimer-type dementia.

Authors:  T Nishimura; H Akiyama; S Yonehara; H Kondo; K Ikeda; M Kato; E Iseki; K Kosaka
Journal:  Brain Res       Date:  1995-10-16       Impact factor: 3.252

8.  Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis.

Authors:  M Enari; R V Talanian; W W Wong; S Nagata
Journal:  Nature       Date:  1996-04-25       Impact factor: 49.962

9.  Fas ligand in human serum.

Authors:  M Tanaka; T Suda; K Haze; N Nakamura; K Sato; F Kimura; K Motoyoshi; M Mizuki; S Tagawa; S Ohga; K Hatake; A H Drummond; S Nagata
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  55 in total

1.  Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system.

Authors:  B Parra; M T Lin; S A Stohlman; C C Bergmann; R Atkinson; D R Hinton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Robert S Fujinami
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Apoptosis of CD4+ T cells occurs in experimental autoimmune anterior uveitis (EAAU).

Authors:  H G Yu; H Chung; W J Lee
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

4.  Multiple sclerosis: death receptor expression and oligodendrocyte apoptosis in established lesions.

Authors:  Barbara Cannella; Stefanie Gaupp; Kakuri M Omari; Cedric S Raine
Journal:  J Neuroimmunol       Date:  2007-07-05       Impact factor: 3.478

5.  Perforin-dependent neurologic injury in a viral model of multiple sclerosis.

Authors:  P D Murray; D B McGavern; X Lin; M K Njenga; J Leibowitz; L R Pease; M Rodriguez
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

6.  T-cell apoptosis in inflammatory brain lesions: destruction of T cells does not depend on antigen recognition.

Authors:  J Bauer; M Bradl; W F Hickley; S Forss-Petter; H Breitschopf; C Linington; H Wekerle; H Lassmann
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 7.  Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

Authors:  J P de Villartay; F Rieux-Laucat; A Fischer; F Le Deist
Journal:  Springer Semin Immunopathol       Date:  1998

8.  Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival.

Authors:  S O Yoon; P Casaccia-Bonnefil; B Carter; M V Chao
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

9.  Human brain astrocytes mediate TRAIL-mediated apoptosis after treatment with IFN-gamma.

Authors:  Jeonggi Lee; Jeon-Soo Shin; In-Hong Choi
Journal:  Yonsei Med J       Date:  2006-06-30       Impact factor: 2.759

10.  APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases.

Authors:  Richa Singh; Vandana Pradhan; Manisha Patwardhan; K Ghosh
Journal:  Indian J Hum Genet       Date:  2009-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.